AR121850A2 - LPA RNA INTERFERENCE AGENT (RNAi), USE OF SAID AGENT AND METHOD FOR INHIBITING LPA EXPRESSION - Google Patents
LPA RNA INTERFERENCE AGENT (RNAi), USE OF SAID AGENT AND METHOD FOR INHIBITING LPA EXPRESSIONInfo
- Publication number
- AR121850A2 AR121850A2 ARP210100996A ARP210100996A AR121850A2 AR 121850 A2 AR121850 A2 AR 121850A2 AR P210100996 A ARP210100996 A AR P210100996A AR P210100996 A ARP210100996 A AR P210100996A AR 121850 A2 AR121850 A2 AR 121850A2
- Authority
- AR
- Argentina
- Prior art keywords
- lpa
- agent
- rnai
- rna interference
- inhibiting
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Agente de interferencia de ARN LPA (ARNi) que comprende una cadena sentido y una cadena antisentido donde dicha cadena antisentido comprende la secuencia de nucleótidos de a) nucleótidos 2 - 19 de cualquiera de las SEQ ID Nº 1 - 108 o b) cualquiera de las cadenas antisentido de la Tabla 1 o Tabla 2ᵃ, uso de dicho agente; y método para inhibir la expresión de LPA en una célula, tejido, o sujeto.LPA RNA interference agent (RNAi) comprising a sense strand and an antisense strand wherein said antisense strand comprises the nucleotide sequence of a) nucleotides 2-19 of any of SEQ ID NOs 1-108 or b) any of the strands antisense from Table 1 or Table 2ᵃ, use of said agent; and method of inhibiting expression of LPA in a cell, tissue, or subject.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562235816P | 2015-10-01 | 2015-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR121850A2 true AR121850A2 (en) | 2022-07-13 |
Family
ID=60923936
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160103006A AR106227A1 (en) | 2015-10-01 | 2016-09-30 | COMPOSITIONS AND METHODS TO INHIBIT THE GENE EXPRESSION OF THE APO APOLIPOPROTEIN GENE (a) (LPA) |
ARP210100996A AR121850A2 (en) | 2015-10-01 | 2021-04-15 | LPA RNA INTERFERENCE AGENT (RNAi), USE OF SAID AGENT AND METHOD FOR INHIBITING LPA EXPRESSION |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160103006A AR106227A1 (en) | 2015-10-01 | 2016-09-30 | COMPOSITIONS AND METHODS TO INHIBIT THE GENE EXPRESSION OF THE APO APOLIPOPROTEIN GENE (a) (LPA) |
Country Status (1)
Country | Link |
---|---|
AR (2) | AR106227A1 (en) |
-
2016
- 2016-09-30 AR ARP160103006A patent/AR106227A1/en unknown
-
2021
- 2021-04-15 AR ARP210100996A patent/AR121850A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR106227A1 (en) | 2017-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018041973A9 (en) | Chemically modified single-stranded rna-editing oligonucleotides | |
PE20210921A1 (en) | ARNI AGENTS AS INHIBITORS OF SERPINE 1 TRANSCRIPTION AND COMPOSITIONS THAT INCLUDE THEM | |
CY1124845T1 (en) | METHODS OF DELIVERING MONOCLON RNA | |
CO2017007335A2 (en) | Suppression of the arni-induced huntingtin gene | |
EA201991369A1 (en) | MODIFIED RNA GUIDES | |
EA201892467A1 (en) | Oligonucleotide Analogues Aimed at Human LMna | |
MX2024001378A (en) | Defined multi-conjugate oligonucleotides. | |
CO2021018034A2 (en) | Modified gapmer oligonucleotides and methods of use | |
BR112016029178A2 (en) | compositions and methods for the expression of crispr guide rs using the h1 promoter | |
BR112017006469A2 (en) | compositions and methods for inhibiting expression of the gene hao1 (hydroxy acid oxidase 1 (glycolate oxidase)) | |
PE20191351A1 (en) | AAV TREATMENT OF HUNTINGTON'S DISEASE | |
BR112016026950A2 (en) | angiotensinogen (agt) RNA compositions and methods of use thereof | |
PE20211393A1 (en) | ARNi COMPOSITIONS AGAINST COMPLEMENT COMPONENT C5 AND METHODS FOR ITS USE | |
AR102777A1 (en) | COMPOSITIONS OF ARNi AGAINST TMPRSS6 AND METHODS FOR USE | |
WO2016164896A3 (en) | Modulation of smn expression | |
MX2017008587A (en) | NATURALLY OCCURING miRNA FOR CONTROLLING GENE EXPRESSION, AND USE OF SAME. | |
AR100946A1 (en) | COMPOSITIONS AND METHODS TO REGULATE GENE EXPRESSION THROUGH RNA INTERFERENCE | |
PH12020500527A1 (en) | Rna molecules | |
MX2016014760A (en) | Niacinamide for inducing generation of antimicrobial peptides. | |
BR112016002524A2 (en) | molecular targets for the prevention and / or treatment of fibrosis, hypertrophic scars and keloids | |
EP3246406A4 (en) | Gene expression system using stealthy rna, and gene introduction/expression vector including said rna | |
WO2015113004A3 (en) | Oligonucleotides and methods for treatment of cardiomyopathy using rna interference | |
CL2021002842A1 (en) | Inhibitory double-stranded nucleic acid molecules with shortened sense strands | |
EP4335502A3 (en) | Modified u6 promoter system for tissue specific expression | |
IT201700036472A1 (en) | ARMREST AXIAL TRAVELING DEVICE, IN PARTICULAR FOR OFFICE CHAIRS |